TW204353B - - Google Patents

Download PDF

Info

Publication number
TW204353B
TW204353B TW079106165A TW79106165A TW204353B TW 204353 B TW204353 B TW 204353B TW 079106165 A TW079106165 A TW 079106165A TW 79106165 A TW79106165 A TW 79106165A TW 204353 B TW204353 B TW 204353B
Authority
TW
Taiwan
Prior art keywords
coli
toxin
page
patent application
vaccine
Prior art date
Application number
TW079106165A
Other languages
English (en)
Chinese (zh)
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of TW204353B publication Critical patent/TW204353B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TW079106165A 1989-08-18 1990-07-25 TW204353B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89202110 1989-08-18

Publications (1)

Publication Number Publication Date
TW204353B true TW204353B (enExample) 1993-04-21

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
TW079106165A TW204353B (enExample) 1989-08-18 1990-07-25

Country Status (16)

Country Link
US (1) US5750115A (enExample)
EP (1) EP0413378B1 (enExample)
JP (1) JP3031561B2 (enExample)
KR (1) KR0177510B1 (enExample)
CN (1) CN1062605C (enExample)
AU (1) AU635062B2 (enExample)
CA (1) CA2022420C (enExample)
DE (1) DE69016129T2 (enExample)
DK (1) DK0413378T3 (enExample)
ES (1) ES2070266T3 (enExample)
GR (1) GR3015782T3 (enExample)
HU (2) HU210965B (enExample)
IL (1) IL95175A (enExample)
NZ (1) NZ234933A (enExample)
TW (1) TW204353B (enExample)
ZA (1) ZA906100B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042718T3 (es) * 1987-10-26 1993-12-16 Akzo Nv Procedimiento para la preparacion de una vacuna para proteger aves de corral contra septicemia producida por e. coli.
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
JP2001527562A (ja) * 1997-05-16 2001-12-25 メディカル ディフェンス テクノロジーズ エルエルシー リポ多糖コアに対するワクチン
WO1999059626A1 (en) * 1998-05-15 1999-11-25 Mkb Investments Limited Partnership Compositions and method for immunizing poultry
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
EP1934349A4 (en) * 2005-08-30 2009-05-27 Commw Scient Ind Res Org BACTERIAL INTRODUCTION OF BIOLOGICALLY ACTIVE POLYPEPTIDES
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
CN102905522A (zh) 2009-10-12 2013-01-30 新健康科学股份有限公司 用于从红细胞中除去氧的氧消耗装置和方法
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
BR112012008683B8 (pt) 2009-10-12 2022-11-08 Hemanext Inc dispositivo de armazenagem de sangue para armazenar sangue depletado de oxigênio e dióxido de carbono, dispositivo de depleção de oxigênio e dióxido de carbono, método para remover oxigênio e dióxido de carbono de hemácias, sistema de armazenagem de sangue, dispositivo de armazenagem de sangue, método para remover oxigênio de hemácias e método para aumentar os níveis de adenosina trifosfato (atp) nas hemácias
WO2012027582A1 (en) 2010-08-25 2012-03-01 New Health Sciences Method for enhancing red blood cell quality and survival during storage
EP4218412A1 (en) 2010-11-05 2023-08-02 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
US8926980B2 (en) * 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins
AU2012294269B2 (en) 2011-08-10 2016-11-24 Hemanext Inc. Integrated leukocyte, oxygen and/or CO2 depletion, and plasma separation filter device
CA2902061C (en) 2013-02-28 2023-08-08 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
KR20250033333A (ko) 2015-03-10 2025-03-07 헤마넥스트 인코포레이티드 산소 감소 1회용 키트, 장치 및 이의 사용 방법
BR122022005103B1 (pt) 2015-04-23 2023-03-14 Hemanext Inc Dispositivo de armazenamento de sangue para armazenar sangue depletado de oxigênio e método para armazenar sangue depletado de oxigênio
PT3297641T (pt) 2015-05-18 2025-10-09 Hemanext Inc Métodos de armazenamento de sangue total e respetivas composições
CN109195632A (zh) 2016-05-27 2019-01-11 新健康科学股份有限公司 厌氧血液储存和病原体失活方法
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
ES2060580T3 (es) * 1986-03-11 1994-12-01 Shionogi & Co Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.

Also Published As

Publication number Publication date
CA2022420C (en) 2000-03-28
GR3015782T3 (en) 1995-07-31
AU635062B2 (en) 1993-03-11
HU210965B (en) 1995-09-28
JPH03184996A (ja) 1991-08-12
HU905053D0 (en) 1991-01-28
DE69016129D1 (de) 1995-03-02
AU6109990A (en) 1991-02-21
US5750115A (en) 1998-05-12
JP3031561B2 (ja) 2000-04-10
ZA906100B (en) 1991-05-29
NZ234933A (en) 1992-06-25
EP0413378B1 (en) 1995-01-18
IL95175A (en) 1994-05-30
CN1049523A (zh) 1991-02-27
HUT59612A (en) 1992-06-29
EP0413378A1 (en) 1991-02-20
HU211827A9 (en) 1995-12-28
DK0413378T3 (da) 1995-05-15
DE69016129T2 (de) 1995-05-24
CN1062605C (zh) 2001-02-28
IL95175A0 (en) 1991-06-10
KR910004209A (ko) 1991-03-28
CA2022420A1 (en) 1991-02-19
KR0177510B1 (ko) 1999-03-20
ES2070266T3 (es) 1995-06-01

Similar Documents

Publication Publication Date Title
US20210347858A1 (en) Alimentary and systemic antiviral therapeutics
JP3031561B2 (ja) 大腸菌ワクチン
ES2534332T3 (es) Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
ES2594102T3 (es) Mutantes por deleción de la flagelina y métodos para su uso
Frasch et al. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.
JPS61502957A (ja) 大腸菌のｌｔ―ｂエンテロトキシンサブユニットと莢膜ポリマーとの免疫原性結合体
Banerjee-Bhatnagar et al. Expression of Neisseria meningitidis iron-regulated outer membrane proteins, including a 70-kilodalton transferrin receptor, and their potential for use as vaccines
BR112015009541B1 (pt) novos adjuvantes de mucosa e sistemas de aplicação
Yang et al. Lactobacillus plantarum displaying conserved M2e and HA2 fusion antigens induces protection against influenza virus challenge
CN113173977A (zh) 一种双功能抗原、其制备方法及应用
CN108823218A (zh) 鸡传染性法氏囊病病毒vp2基因、其表达产物、其亚单位疫苗及应用
KR940010861B1 (ko) 세포연관 글루코실트랜스퍼라제, 그의 항체 및 유효성분으로서 상기 항체를 함유하는 이의 카리에스 예방 조성물
CN102140430A (zh) 一种不含抗性标记的鼠伤寒沙门氏菌基因缺失突变菌株、疫苗及应用
CN105175549B (zh) 一种流感嗜血杆菌融合蛋白及其构建方法与应用
PT680765E (pt) Vacina para estirpe não tipável de haemophilus influenzae.
PT88850B (pt) Processo de preparacao de vacina e de composicao contra a septicemia por e. coli em aves domesticas
CN108619501A (zh) 抗rsv和脑膜炎球菌缀合疫苗及其制备方法
Kim et al. Inactivated Vibrio cholerae strains that express TcpA via the toxT-139F allele induce antibody responses against TcpA
Vandemaele et al. Immunization with the biologically active lectin domain of PapGII induces strong adhesion-inhibiting antibody responses but not protection against avian pathogenic Escherichia coli
CZ20011947A3 (cs) Orální vakcína proti diarea
TW200418874A (en) Passive vaccine for the prevention of campylobacter colonization, and its preparation method
CN114073766A (zh) 一种幽门螺杆菌表位肽及其应用
CN104587461A (zh) 伤寒、甲型乙型副伤寒多糖蛋白结合型多价联合疫苗
RU2683027C2 (ru) Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию
TWI776097B (zh) 增強免疫力或抗病力的食品添加劑